Cytokine Secretion Dynamics of Isolated PBMC after Cladribine Exposure in RRMS Patients

Cladribine (CLD) treats multiple sclerosis (MS) by selectively and transiently depleting B and T cells with a secondary long-term reconstruction of the immune system. This study provides evidence of CLD’s immunomodulatory role in peripheral blood mononuclear cells (PBMCs) harvested from 40 patients...

Descripción completa

Detalles Bibliográficos
Autores principales: Balasa, Rodica, Maier, Smaranda, Hutanu, Adina, Voidazan, Septimiu, Andone, Sebastian, Oiaga, Mirela, Manu, Doina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9499495/
https://www.ncbi.nlm.nih.gov/pubmed/36142168
http://dx.doi.org/10.3390/ijms231810262

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9499495/
https://www.ncbi.nlm.nih.gov/pubmed/36142168
http://dx.doi.org/10.3390/ijms231810262

Ejemplares similares